chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Body temperature, Chills, Diarrhoea, Headache
Clinical narrative: RUNNY NOSE; DIARRHEA; SORE THROAT; LOSS OF TASTE; VOMITING; UP ALL NIGHT; CHILLS; FEVER 101; HEADACHE; This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included lactose intolerant, seasonal allergies, non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies. the patient had no drug abuse or illicit drug use. the patient was not pregnant at the time of reporting.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced runny nose. On 08-APR-2021, the subject experienced diarrhea. On 08-APR-2021, the subject experienced sore throat. On 08-APR-2021, the subject experienced loss of taste. On 08-APR-2021, the subject experienced vomiting. On 08-APR-2021, the subject experienced up all night. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever 101. On 08-APR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea, vomiting, chills, and fever 101 on APR-2021, had not recovered from headache, sore throat, runny nose, and loss of taste, and the outcome of up all night was not reported. This report was non-serious.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Oropharyngeal pain, Pyrexia, Rhinorrhoea, Vomiting
Clinical narrative: RUNNY NOSE; DIARRHEA; SORE THROAT; LOSS OF TASTE; VOMITING; UP ALL NIGHT; CHILLS; FEVER 101; HEADACHE; This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included lactose intolerant, seasonal allergies, non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies. the patient had no drug abuse or illicit drug use. the patient was not pregnant at the time of reporting.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced runny nose. On 08-APR-2021, the subject experienced diarrhea. On 08-APR-2021, the subject experienced sore throat. On 08-APR-2021, the subject experienced loss of taste. On 08-APR-2021, the subject experienced vomiting. On 08-APR-2021, the subject experienced up all night. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever 101. On 08-APR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea, vomiting, chills, and fever 101 on APR-2021, had not recovered from headache, sore throat, runny nose, and loss of taste, and the outcome of up all night was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Dehydration, Heart rate increased, Pain, Pyrexia
Clinical narrative: DEHYDRATED PER ER; FAST HEART RATE; ACHES; FEVER; This spontaneous report received from a patient concerned a 63 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry:23/JUN/2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021 02:00, the subject experienced aches. On 07-APR-2021 02:00, the subject experienced fever. On 07-APR-2021 04:00, the subject experienced fast heart rate. On an unspecified date, the subject experienced dehydration. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fast heart rate on 07-APR-2021, was recovering from fever, and aches, and the outcome of dehydration was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Sensitive skin
Clinical narrative: SUPER SENSITIVE IN THE CENTER OF ARM PIT OF RIGHT ARM; ARM PIT OF RIGHT ARM SWOLLEN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced super sensitive in the center of arm pit of right arm, and arm pit of right arm swollen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the super sensitive in the center of arm pit of right arm and arm pit of right arm swollen was not reported. This report was non-serious.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia, Vomiting
Clinical narrative: SEVERE PAIN IN TEMPLE; VOMITING; ACHINESS; CHILLS; FEVER; This spontaneous report received from a consumer concerned a 19 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 40z1AZ1A, expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced fever. On 06-APR-2021, the subject experienced severe temple pain. On 06-APR-2021 03:00, the subject experienced vomiting. On 06-APR-2021 03:00, the subject experienced achiness. On 06-APR-2021 03:00, the subject experienced chills. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting, achiness, chills, fever, and severe temple pain on 06-APR-2021 13:00. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Pain, Pyrexia
Clinical narrative: BODY ACHES; UPSET STOMACH/STOMACH ACHE/SLIGHT DIARRHEA; FEVER 100F; This spontaneous report received from a patient concerned a 49 year old of unspecified sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 421A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021 01:00, the subject experienced body aches. On 09-APR-2021 01:00, the subject experienced upset stomach/stomach ache/slight diarrhea. On 09-APR-2021 01:00, the subject experienced fever 100f. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 100 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body aches, fever 100f and upset stomach/stomach ache/slight diarrhea was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain in extremity
Clinical narrative: SORENESS IN THE ARM; CHILLS; HEADACHE; EXTREME EXHAUSTION; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included cold prior taking vaccination.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808982 expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 10:00 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced soreness in the arm, chills, headache, and extreme exhaustion. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, extreme exhaustion, chills and soreness in the arm was not reported. This report was non-serious. This case, from the same reporter is linked to 20210421193.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hot flush, Myalgia, Nausea
Clinical narrative: FEELING A LITTLE SHAKY; NAUSEA; HEADACHE; MUSCLE ACHES ON THE LEFT SIDE OF THE BODY; VOMITING; SHAKINESS; HOT FLASHES; DIZZINESS; This spontaneous report received from a patient concerned a 28 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced vomiting. On 08-APR-2021, the subject experienced shakiness. On 08-APR-2021, the subject experienced hot flashes. On 08-APR-2021, the subject experienced dizziness. On 08-APR-2021, the subject experienced nausea. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced muscle aches on the left side of the body. On 10-APR-2021, the subject experienced feeling a little shaky. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting, shakiness, hot flashes, dizziness, nausea, and muscle aches on the left side of the body on 09-APR-2021, and had not recovered from headache, and feeling a little shaky. This report was non-serious.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Nervousness, Tremor, Vomiting
Clinical narrative: FEELING A LITTLE SHAKY; NAUSEA; HEADACHE; MUSCLE ACHES ON THE LEFT SIDE OF THE BODY; VOMITING; SHAKINESS; HOT FLASHES; DIZZINESS; This spontaneous report received from a patient concerned a 28 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced vomiting. On 08-APR-2021, the subject experienced shakiness. On 08-APR-2021, the subject experienced hot flashes. On 08-APR-2021, the subject experienced dizziness. On 08-APR-2021, the subject experienced nausea. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced muscle aches on the left side of the body. On 10-APR-2021, the subject experienced feeling a little shaky. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting, shakiness, hot flashes, dizziness, nausea, and muscle aches on the left side of the body on 09-APR-2021, and had not recovered from headache, and feeling a little shaky. This report was non-serious.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Muscle tightness, Pain, Pyrexia
Clinical narrative: BODY ACHE; FELT FLEXED; SUPER FLUEY AND OFFAL; CHILLS; FEVER; This spontaneous report received from a patient concerned a 36 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201821A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced body ache. On 07-APR-2021, the subject experienced felt flexed. On 07-APR-2021, the subject experienced super fluey and offal. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, felt flexed, super fluey and offal, chills, and fever on 09-APR-2021. This report was non-serious.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Incorrect dose administered, Injection site pain, Pain
Clinical narrative: BODY ACHES; JOINT PAIN; HEADACHE; INJECTION SITE PAIN /SEVERE ARM PAIN; PASSED OUT AT INJECTION; This spontaneous report received from a patient concerned a 26 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included vonn willebrand's disease, non-alcoholic, non-smoker, and needle phobia, and other pre-existing medical conditions included the patient had no known allergies and no drug abuse or illicit drug. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced passed out at injection. On 12-MAR-2021, the subject experienced injection site pain /severe arm pain. On 13-MAR-2021, the subject experienced body aches. On 13-MAR-2021, the subject experienced joint pain. On 13-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, joint pain, and headache on 15-MAR-2021, had not recovered from injection site pain /severe arm pain, and the outcome of passed out at injection was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Rash
Clinical narrative: SWOLLEN LIPS; RED SPOTS ON BODY; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included lactose allergy, and bees allergy. The patient experienced drug allergy when treated with lithium. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982,expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 16:45 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced swollen lips. On 08-APR-2021, the subject experienced red spots on body. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from swollen lips, and red spots on body. This report was non-serious.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Feeling abnormal, Hypertension, Injection site reaction, Musculoskeletal stiffness
Clinical narrative: ELEVATED BLOOD PRESSURE; NECK STIFFNESS; FUZZY HEAD; BUMP BELOW THE INJECTION SITE; PAIN IN ARM; This spontaneous report received from a patient concerned a 59 year old female. The patient's weight, height, and medical history were not reported. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported,1 total administered on 08-APR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the patient felt pain in the arm, stiffness in the neck 30 minutes after receiving the vaccine. She had a bump not where she got the shot but below the injection site and also had fuzzy head. She had elevated blood pressure (173/103) and her normal blood pressure was (118/75). It was reported that all the symptoms were still persisting. Laboratory data included: Blood pressure (NR: not provided) 173/103. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in arm, neck stiffness, bump below the injection site, fuzzy head, and elevated blood pressure. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210420595-JANSSEN COVID-19 VACCINE Ad26.COV2.S- Elevated blood pressure. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: ELEVATED BLOOD PRESSURE; NECK STIFFNESS; FUZZY HEAD; BUMP BELOW THE INJECTION SITE; PAIN IN ARM; This spontaneous report received from a patient concerned a 59 year old female. The patient's weight, height, and medical history were not reported. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported,1 total administered on 08-APR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the patient felt pain in the arm, stiffness in the neck 30 minutes after receiving the vaccine. She had a bump not where she got the shot but below the injection site and also had fuzzy head. She had elevated blood pressure (173/103) and her normal blood pressure was (118/75). It was reported that all the symptoms were still persisting. Laboratory data included: Blood pressure (NR: not provided) 173/103. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in arm, neck stiffness, bump below the injection site, fuzzy head, and elevated blood pressure. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210420595-JANSSEN COVID-19 VACCINE Ad26.COV2.S- Elevated blood pressure. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Off label use, Product administered to patient of inappropriate age
Clinical narrative: DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE/PATIENT WAS GIVEN THE JANSSEN  COVID-19 VACCINE, PT IS ONLY 16 YEARS; OFF LABEL USE; HEADACHE; This spontaneous report received from a patient concerned a 16 year old male. The patient's weight was not reported and height was 5.9 inches. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: 23/JUN/2021) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced drug administered to subject of inappropriate age. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 09-APR-2021, and the outcome of drug administered to patient of inappropriate age and off label use was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Needle issue, Pain in extremity, Underdose
Clinical narrative: ARM SORENESS; PARTIAL DOSE ADMINISTERED; THE NEEDLE LEAKED OFF; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-APR-2021, the subject experienced partial dose administered. On an unspecified date, the subject experienced the needle leaked off, and arm soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the partial dose administered, arm soreness and the needle leaked off was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: FATIGUE; SLEEPY; iThis spontaneous report received from a patient concerned a 76 year old of unspecified sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 11R1511T27, and  expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced sleepy, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fatigue, and the outcome of sleepy was not reported. This report was non-serious.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Nasal congestion, Pyrexia
Clinical narrative: NASAL CONGESTION; SWEATING; FEVER; MODERATE HEADACHE; This spontaneous report received from a patient concerned a 54 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included cerebral palsy, sleep apnea, high blood pressure, chronic fatigue, nonsmoker, nonalcohol, and muscle spasms.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: not reported) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. Concomitant medications included baclofen for drug used for unknown indication, hydrocodone bitartrate/paracetamol for drug used for unknown indication, ascorbic acid/herbal nos/levoglutamide/lysine/magnesium/manganese/retinol/riboflavin/selenium/tocopherol/zinc for nasal congestion, loratadine for nasal congestion, and modafinil. On APR-2021, treatment medications included: ibuprofen, and paracetamol. On 09-APR-2021, the subject experienced nasal congestion. On 09-APR-2021, the subject experienced sweating. On 09-APR-2021, the subject experienced fever. On 09-APR-2021, the subject experienced moderate headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from nasal congestion, fever, moderate headache, and sweating. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Myalgia, Pyrexia
Clinical narrative: FEVER; CHILLS; HEADACHE; DIZZINESS; MUSCLE ACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch no was not reported and has been requested. No concomitant medications were reported. On 06-APR-2021, the subject experienced fever. On 06-APR-2021, the subject experienced chills. On 06-APR-2021, the subject experienced headache. On 06-APR-2021, the subject experienced dizziness. On 06-APR-2021, the subject experienced muscle ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, headache, dizziness, and muscle ache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain in extremity, Pyrexia
Clinical narrative: CHILLS; SORE ARM; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 15:00 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced sore arm. On 10-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 97 (unit not reported), 100.6 (unit not reported). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, and fever, and the outcome of sore arm was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Application site rash, Rash, Skin induration, Tenderness
Clinical narrative: SORE TO TOUCH; HARD AND KNOTTED; OVAL SHAPED; UNCONFIRMED FACE RASH; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination.  The Batch number was not reported and has been requested. No concomitant medications were reported. No concomitant medications were reported. On 09-APR-2021, the subject experienced sore to touch. On 09-APR-2021, the subject experienced hard and knotted. On 09-APR-2021, the subject experienced oval shaped. On 09-APR-2021, the subject experienced unconfirmed face rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sore to touch, hard and knotted, and oval shaped, and the outcome of unconfirmed face rash was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: DIZZY; HEADACHE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 08-APR-2021, the subject experienced dizzy. On 08-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from dizzy, and headache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: BODY ACHES (MUSCLES, BONES AND  JOINTS); HEADACHE; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 13:30 for prophylactic vaccination. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. No concomitant medications were reported. On an unspecified date, the subject experienced body aches (muscles, bones and joints), headache, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches (muscles, bones and joints), and fever, and headache on 09-APR-2021. This report was non-serious.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: BODY ACHES; CHILLS; This spontaneous report received from a patient concerned a 60 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and expiry: 09-JUN-2021) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-MAR-2021, the subject experienced body aches. On 24-MAR-2021, the subject experienced chills. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and chills on 25-MAR-2021. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Pyrexia
Clinical narrative: FLU LIKE SYMPTOMS; CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported.  The patient's concurrent conditions included non alcohol user, non smoker, and drug allergy, and other pre-existing medical conditions included no drug abuse or illicit usage reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042a21a, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 09:00 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced fever. On an unspecified date, the subject experienced flu like symptoms, chills, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, headache, chills, and flu like symptoms. This report was non-serious.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Pyrexia
Clinical narrative: DIARRHEA; CHILLS; FEVER; This spontaneous report received from a health care professional concerned a 57 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A214, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced diarrhea. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.5 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea, and was recovering from fever, and chills. This report was non-serious.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Urticaria, Vertigo
Clinical narrative: HIVES RASH; VERTIGO; FLU LIKE SYMPTOMS; FATIGUE; This spontaneous report received from a patient concerned a 31 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included anxiety, and non smoker. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 at 11:50 AM for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced fatigue. On 03-APR-2021, the subject experienced flu like symptoms. On 06-APR-2021, the subject experienced vertigo. On 09-APR-2021 23:30, the subject experienced hives rash. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on 05-APR-2021, vertigo on 07-APR-2021, and fatigue on 09-APR-2021, and had not recovered from hives rash. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Nausea, Pyrexia
Clinical narrative: Respiratory disorder; HEADACHE; NAUSEA; VERY EXTREME EXHAUSTION; FEVER; This spontaneous report received from a patient concerned a 71 year old female. The patient's height, and weight were not reported. The patient's past medical history included Addison disease, and concurrent conditions included COPD, Bipolar disorder, Hypothyroidism, Diabetes, and GERD, and other pre-existing medical conditions included the patient had long list of allergy but declined as reporter was in a hurry. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced respiratory disorder. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced nausea. On 09-APR-2021, the subject experienced very extreme exhaustion. On 09-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 99.8 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from respiratory disorder, headache, nausea, very extreme exhaustion, and fever. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Respiratory disorder
Clinical narrative: Respiratory disorder; HEADACHE; NAUSEA; VERY EXTREME EXHAUSTION; FEVER; This spontaneous report received from a patient concerned a 71 year old female. The patient's height, and weight were not reported. The patient's past medical history included Addison disease, and concurrent conditions included COPD, Bipolar disorder, Hypothyroidism, Diabetes, and GERD, and other pre-existing medical conditions included the patient had long list of allergy but declined as reporter was in a hurry. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced respiratory disorder. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced nausea. On 09-APR-2021, the subject experienced very extreme exhaustion. On 09-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 99.8 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from respiratory disorder, headache, nausea, very extreme exhaustion, and fever. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Nausea, Pain, Pyrexia
Clinical narrative: BODY ACHE; VOMITING; DIARRHEA; CHILLS; FEVER; NAUSEA; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose, start therapy date were not reported for prophylactic vaccination.The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced body ache, vomiting, diarrhea, chills, fever, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, body ache, nausea, vomiting and diarrhea was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: BODY ACHE; VOMITING; DIARRHEA; CHILLS; FEVER; NAUSEA; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose, start therapy date were not reported for prophylactic vaccination.The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced body ache, vomiting, diarrhea, chills, fever, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, body ache, nausea, vomiting and diarrhea was not reported. This report was non-serious.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Retching
Clinical narrative: DRY HEAVES; COUGH; This spontaneous report received from a consumer concerned an 80 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes, and other pre-existing medical conditions included no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-APR-2021 14:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 11-APR-2021, the subject experienced dry heaves. On 11-APR-2021, the subject experienced cough. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dry heaves, and cough. This report was non-serious.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Nausea, Pyrexia
Clinical narrative: CHILLS; HIGH FEVER; NAUSEA; VERY TIRED; This spontaneous report received from a consumer concerned a 29 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unkown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced chills. On 09-APR-2021, the subject experienced high fever. On 09-APR-2021, the subject experienced nausea. On 09-APR-2021, the subject experienced very tired. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 102.7 F, 103.2 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the high fever, chills, nausea and very tired was not reported. This report was non-serious.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: METALLIC TASTE; This spontaneous report received from a patient concerned a 30 year old. The patient's height, and weight were not reported. The patient's concurrent conditions included hypertension, anxiety, alcohol use occasionally once per month or once every 3 months, and smoke marijuana twice daily for anxiety, and other pre-existing medical conditions included no known allergies and no history of drug abuse/ illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. Concomitant medications included lisinopril for hypertension.  On 10-APR-2021, the subject experienced metallic taste. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from metallic taste on 10-APR-2021. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Malaise, Pyrexia
Clinical narrative: MALAISE; FEVER; This spontaneous report received from a patient concerned an 84 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 27-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 100 F. On 06-APR-2021, Laboratory data included: Body temperature (NR: not provided) 96 F, 99.3 F. On an unspecified date, the patient experienced fever, and malaise. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever and malaise was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a patient concerned a 44 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included hypertension, and other pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1850220, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache. This report was non-serious.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: CHILLS; LIGHT FEVER; HEADACHE; This spontaneous report received from a patient concerned a 29 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On APR-2021, the subject experienced chills. On APR-2021, the subject experienced light fever. On APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the light fever, chills and headache was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Feeling jittery, Headache, Influenza like illness
Clinical narrative: SKIN SENSITIVITY; NECK SORENESS; BACK SORENESS; HEADACHE; SHAKYNESS; FLU LIKE SYMPTOMS; OVERALL WEAKNESS; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included sensitive to morphine and Codiene. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: 09-JUN-2021) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination.  No concomitant medications were reported.  On 09-APR-2021, the subject experienced skin sensitivity. On 09-APR-2021, the subject experienced neck soreness. On 09-APR-2021, the subject experienced back soreness. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced Shakyness. On 09-APR-2021, the subject experienced flu like symptoms. On 09-APR-2021, the subject experienced overall weakness. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) NEGATIVE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from skin sensitivity, Headache, Shakyness, and flu like symptoms, and was recovering from Neck Soreness, Overall Weakness, and Back soreness. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, SARS-CoV-2 test, Sensitive skin
Clinical narrative: SKIN SENSITIVITY; NECK SORENESS; BACK SORENESS; HEADACHE; SHAKYNESS; FLU LIKE SYMPTOMS; OVERALL WEAKNESS; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included sensitive to morphine and Codiene. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: 09-JUN-2021) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination.  No concomitant medications were reported.  On 09-APR-2021, the subject experienced skin sensitivity. On 09-APR-2021, the subject experienced neck soreness. On 09-APR-2021, the subject experienced back soreness. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced Shakyness. On 09-APR-2021, the subject experienced flu like symptoms. On 09-APR-2021, the subject experienced overall weakness. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) NEGATIVE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from skin sensitivity, Headache, Shakyness, and flu like symptoms, and was recovering from Neck Soreness, Overall Weakness, and Back soreness. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: MUSCLE PAIN; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced muscle pain. On 10-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from muscle pain, and fever. This report was non-serious.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Feeling hot, Headache, Pain
Clinical narrative: BODY ACHES; FEELING HOT; IN BED WHOLE DAY; HEADACHE; This spontaneous report received from a patient via a company representative concerned a 43 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 08-APR-2021 10:30 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced feeling hot. On 08-APR-2021, the subject experienced in bed whole day. On 08-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, feeling hot, in bed whole day, and headache on 10-APR-2021. This report was non-serious.